SCHEMBL7478595

SCHEMBL7478595

C=CCOC(=O)Cl.[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37486 0.97
SCHEMBL27546354 0.97 CYP3A4 (0.46)
Water SCHEMBL27610249 0.94
SCHEMBL28130290 0.87 MAPT (0.42)
SCHEMBL28101523 0.85 CYP3A4 (0.39)
SCHEMBL11833138 0.84 TDP1 (0.49)
SCHEMBL6570568 0.82 MEN1 (0.44)
SCHEMBL8038272 0.80 CYP3A4 (0.39)
SCHEMBL11524652 0.80 CYP3A4 (0.36)
SCHEMBL27669465 0.80 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6441019-B2 E. G., 6-(3-CHLOROPHENYL)-1,4-DIHYDRO-4,4-DIMETHYL-2H-THIENO-(2,3-D)(1,3) OXAZINE-2-ONE; AGONISTS AND ANTAGONISTS OF THE PROGESTERONE RECEPTOR; INDUCING CONTRACEPTION AND TREATING OR PREVENTING BENIGN OR MALIGNANT NEOPLASTIC DISEASES WYETH 2002-08-27 US disclosed
US-6380178-B1 CONTRACEPTION WHICH COMPRISES ADMINISTERING TO A FEMALE OF FOR 28 CONSECUTIVE DAYS: FIRST PHASE OF FROM 14 TO 24 DAILY DOSAGE UNITS OF A PROGESTATIONAL AGENT LEVONORGESTREL; SECOND PHASE OF FROM 1 TO 11 DAILY DOSAGE UNITS OF ANTIPROGESTIN COMPOUND AMERICAN HOME PRODUCTS CORPORATION 2002-04-30 US disclosed
EP-1185535-A1 CYCLOCARBAMATE AND CYCLIC AMIDE DERIVATIVES American Home Products Corporation (US) 2002-03-13 EP disclosed
EP-1173253-A1 CONTRACEPTIVE COMPOSITIONS CONTAINING CYCLIC CARBAMATES AND AMIDE DERIVATIVES American Home Products Corporation (US) 2002-01-23 EP disclosed
US-20020002173-A1 Cyclocarbamate and cyclic amide derivatives LIGAND PHARMACEUTICALS INCORPORATED 2002-01-03 US disclosed
US-6306851-B1 ADMINISTERING TO A MAMMAL A COMPOUND FOR BENIGN OR MALIGNANT NEOPLASTIC DISEASE IS SELECTED FROM UTERINE MYOMETRIAL FIBROIDS, ENDOMETRIOSIS, BENIGN PROSTATIC HYPERTROPHY; AMERICAN HOME PRODUCTS CORPORATION 2001-10-23 US disclosed
WO-2000066225-A1 CONTRACEPTIVE COMPOSITIONS CONTAINING CYCLIC CARBAMATES AND AMIDE DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-11-09 WO disclosed
WO-2000066591-A1 CYCLOCARBAMATE AND CYCLIC AMIDE DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-11-09 WO disclosed